Recent Research | Page 77 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Titlesort descending Original Publication Date Journal Bone Marrow Disease
Treatment of Higher-Risk Myelodysplastic Syndromes After Failure of Hypomethylating Agents Jun 2015 Clin Lymphoma Myeloma Leuk myelodysplastic syndromes (MDS)
Treatment of low-risk myelodysplastic syndromes Dec 2016 Hematology Am Soc Hematol Educ Program myelodysplastic syndromes (MDS)
Treatment of Older Patients with High-Risk Myelodysplastic Syndromes (MDS): The Emerging Role of Allogeneic Hematopoietic Stem Cell Transplantation (Allo HSCT). Jan 2014 Curr Hematol Malig Rep myelodysplastic syndromes (MDS)
Treatment options for patients with myelodysplastic syndromes after hypomethylating agent failure Dec 2016 Hematology Am Soc Hematol Educ Program myelodysplastic syndromes (MDS)
Under-recognition of Platelet dysfunction in Myelodysplastic Syndromes: are we only seeing the tip of the iceberg? Aug 2012 Leuk Lymphoma myelodysplastic syndromes (MDS)
Unraveling Myelodysplastic Syndromes: Current Knowledge and Future Directions Jan 2016 Curr Oncol Rep myelodysplastic syndromes (MDS)
Unrelated cord blood transplantation for newly diagnosed patients with severe acquired aplastic anemia using a reduced-intensity conditioning: high graft rejection, but good survival. Jan 2012 Bone Marrow Transplant aplastic anemia
Unrelated cord blood transplantation in a child with very severe aplastic anemia Dec 2012 Rinsho Ketsueki aplastic anemia
Unrelated Hematopoietic Cell Transplantation in Aplastic Anemia: There Is More to a Successful Outcome Than Meets the Eye May 2015 JAMA Oncol aplastic anemia
Unveiling the paradoxical nature of myelodysplastic syndromes (MDS): Why hypercellular marrow strongly favors accelerated apoptosis. Mar 2013 Biochem Cell Biol myelodysplastic syndromes (MDS)